AcelRx Pharma Stock Price (NASDAQ:ACRX)

Add to My Stocks
$3.1 $0 (0%) ACRX stock closing price Feb 17, 2017 (Closing)
AcelRx Pharma
17 FEB 2017
amigobulls logo
ACRX hand_up
ACRX vs S&P 500
Closing Price: Feb 17, 2017
$3.1 ( 0%)
S&P 500
2351.2 ( 0.17%)
52 Week Price Range
1 Year Return: -14.36%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

AcelRx Pharma Snapshot Video

10 5 2

ACRX Stock Details

Prev Close* : $3.10
Market Cap:
Day Low: $3
52 Week Low: $2.40
Open: $3.15
Volume: 178015
Day High: $3.15
52 Week High: $4.50

Latest Stock Market News

Latest Articles

AcelRx Pharma News - From Partners

ACRX Stockcharts

View ACRX PE ratio, PS ratio stocks charts and compare with peers.
ACRX Chart
Note: Compare AcelRx Pharma stock price history with the index and industry peers.

AcelRx Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

AcelRx Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

ACRX Industry Peers

Company Price Change (%)
Durect (DRRX)1.010.02 (2.02%)
Arrowhead Pharma (ARWR)2.170.02 (0.91%)
Depomed (DEPO)16.470.38 (2.26%)
Biodelivery Sciences (BDSI)1.880 (0%)
Cara Therapeutics (CARA)14.760.23 (1.58%)
Acura Pharma (ACUR)0.860.03 (3.37%)
Egalet (EGLT)5.030.03 (0.6%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Esperion Therapeutics (ESPR)251.81 (7.81%)
Cempra (CEMP)3.350.18 (5.67%)
Portola Pharma (PTLA)31.681.41 (4.66%)
Tesaro Inc (TSRO)190.367.8 (4.27%)
Genocea Biosciences (GNCA)4.60.16 (3.6%)
Achaogen (AKAO)22.680.68 (3.09%)
ChemoCentryx (CCXI)7.040.21 (3.07%)
Top gainers from Medical-Drugs industry
* As of Feb 18, 2017
CompanyPriceChange (%)
ArQule (ARQL)1.20.27 (18.37%)
Infinity Pharma (INFI)2.440.13 (5.06%)
ImmunoGen (IMGN)2.430.07 (2.8%)
Lannett Co (LCI)22.40.6 (2.61%)
Zogenix (ZGNX)10.20.25 (2.39%)
La Jolla Pharma (LJPC)18.970.46 (2.37%)
Depomed (DEPO)16.470.38 (2.26%)
Top losers from Medical-Drugs industry
* As of Feb 18, 2017

AcelRx Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues19.26M5.21M29.5M2.39M1.07M
Net Income-24.39M-33.35M-23.42M-33.36M-20.1M
Total Operating Expense37.43M42.86M36.16M32.09M20.42M
view AcelRx Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets127.78M86.44M110.03M64.52M40.83M
Total Liabilities94.67M39.79M36.87M30.67M23.36M
Shareholders Equity33.11M46.65M73.15M33.84M17.46M
view AcelRx Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-4.42M-0.13M2.95M3.51M2.16M
Net Cash From (Used By) Operating Activities-19.95M-34.45M-0.48M-24.58M-15.28M
Increase (Decrease) In Prop Plant And Equipment-1.45M-5.5M-3.28M-0.82M-2.01M
view AcelRx Pharmaceuticals Inc cashflow statement

AcelRx Pharma Stock Message Board

AcelRx Pharma stock lost 0 %, and the last close price as of 17 Feb, 2017 is 3.1 for ACRX stock. AcelRx Pharma market capitalization is 140.54M and it represents the total market value of ACRX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing AcelRx Pharma stock analysis.

For recognizing and analyzing the real performance of AcelRx Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 178015 shares were traded with a closing stock price of 3.1 as of 17 Feb, 2017, as can be seen from AcelRx Pharma stock quote. One can view AcelRx Pharma stock chart to follow the stock price trend. One can observe stock price trends and check for volatility by checking AcelRx Pharma stock price history.